Global Sacroiliac Joint Fusion Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Sacroiliac Joint Fusion Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Sacroiliac joint fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. It is performed for a variety of conditions including trauma, infection, cancer, and spinal instability. There are two sacroiliac joints that connect the sacrum, located at the base of the spine, to the iliac bones, which make up the pelvis. When the ligaments or bony surfaces are damaged, due to trauma, arthritis or other conditions, the sacroiliac joints can be the source of intense pain that may radiate into the leg. Sacroiliac joint fusion is one of the newest and best procedures to provide relief for sacroiliac pain.

Market Overview:

The latest research study on the global Sacroiliac Joint Fusion market finds that the global Sacroiliac Joint Fusion market reached a value of USD 300.18 million in 2022. It’s expected that the market will achieve USD 699.81 million by 2028, exhibiting a CAGR of 15.15% during the forecast period.

Influence of COVID-19 Outbreak on Sacroiliac Joint Fusion Industry Development

The global outbreak of coronavirus pandemic has had a severe impact on the industry. Disruption in supply chains, movement restrictions, and a temporary halt in factory production had limited the sales and production of various systems being used for sacroiliac joint fusion. Also, various industry leaders pivoted to manufacturing COVID essentials to support the fight against coronavirus, further affecting the market progression. Like all orthopedic market segments, sacroiliac joint fusion volumes declined precipitously due to COVID-19. Given the late-June surge in COVID cases, it is expected orthopedic volumes to remain depressed throughout 2020. Therefore, it is expected that the growth rate of the Sacroiliac Joint Fusion market in 2020 will be slower than in previous years, but due to the large demand, the overall growth rate will continue.

Apart from this, the COVID-19 outbreak has resulted in the closing down of several manufacturing facilities across the globe. The pandemic caused huge revenue losses in end-use industry. The coronavirus lockdown put a brake on the production of several key raw materials in the global market, which, in turn, spiked the prices and lowered the demand for the product. The strict lockdown mandates imposed by governments have restricted cross-border trade between countries, another factor proving to be detrimental for the sacroiliac joint fusion market share. In addition, sacroiliac joint fusion manufacturers are drawing up plans for the international market as a new supply link in the global sacroiliac joint fusion industry, as companies look to re-engineer supply chains in the aftermath of COVID-19. Also, it is expected that the product demand in end-user sectors could pick up following the uplift of the lockdown in numerous countries.

Sacroiliac Joint Fusion Drivers

Sacroiliac joint fusion is an increasingly common treatment for patients with low back pain due to SI joint dysfunction. Sacroiliac (SI) joint dysfunction was once thought to be a less common cause for lower back pain. However, recent studies have shown that SI joint dysfunction (SIJD) may be responsible for up to 30 to 35 percent of lower back pain. Growth of this spinal treatment has historically been limited by the diagnosis process. One important factor in the future growth of the SI joint fusion market is new information surrounding adjacent segment disease. Dysfunction of the SI joint may cause low back and/or leg pain that is typically worse when standing and walking. Published clinical literature indicates that sacroiliac joint pain is estimated to affect between 15 and 30 percent of individuals with chronic low back pain. Common causes that may lead to SI joint dysfunction and pain include trauma, lifting or twisting, pregnancy, natural childbirth, degeneration from previous lumbar spine surgery, stresses to the joint due to leg length differences, joint replacement, or scoliosis among others.

Sacroiliac joint fusion is an increasingly common treatment for patients with low back pain due to SI joint dysfunction. Therefore, it represents a high-growth potential niche in the orthopedic spine market. Sacroiliac Joint Fusion Market size is projected to record massive gains from 2021 to 2027 led by the growing prominence of surgery worldwide. Moreover, an escalation in the geriatric population suffering from joint displacement and pain issues is further likely to augment the market space during the forecast timeframe. The rising cases of road accidents resulting in joint displacement is touted to stimulate the demand for sacroiliac joint fusion treatment.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

SI-BONE is one of the major players operating in the Sacroiliac Joint Fusion market, holding a share of 36% in 2021.

Business Overview and Strategies for Company to Deal with the Impact of COVID-19

SI-BONE® was founded in April 2008, as a spin out when Wright Medical bought INBONE Technologies. INBONE, with the ENDO-FUSETM Intra-Osseous Fusion System, was founded by Dr. Mark Reiley, the inventor of kyphoplasty and the vertebral fracture treatment. SI-BONE is a medical device company that pioneered the iFuse Implant System, a minimally invasive surgical system for fusion of the sacroiliac joint to treat sacroiliac joint dysfunction. The SI joint is believed to be the last major joint with a clinically proven surgical treatment. The iFuse Implant, commercially available since 2009, is believed to be the only SI joint fusion device supported by multiple prospective clinical studies showing improved pain, patient function and quality of life resulting from treatment.
SI-BONE continues to monitor and adhere to the latest safety guidelines established by the CDC, CMS, and relevant state and local authorities. In the interim, SI-BONE is offering web-based training on telehealth and other relevant topics for HCPs, to help provide continuity of care. SI-BONE’s reimbursement team continues to work with surgeon offices and facilities via an online portal, to keep prior authorizations for already diagnosed patients moving through the reimbursement system. Finally, SI-BONE is equipping the field team with appropriate PPE, so that they can safely service HCPs, facilities and patients as reopening occurs.

Business Overview and Strategies for Company to Deal with the Impact of COVID-19

Medtronic believes in the power of medical technology to improve lives. Seven decades ago, Medtronic’s co-founder invented the battery-powered pacemaker. Today, Medtronic is among the largest medical device companies in the world. With operations in 150 countries, Medtronic’s products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more.
Based on collaboration with healthcare systems across the country, Medtronic healthcare optimization consultants have developed a playbook for healthcare leaders focused on restoring capacity, increasing patient access, and improving operational care pathways during both the surge and recovery stages of the COVID-19 pandemic. Responding to an increased demand for remote patient management may require a renewed focus on technology, capacity, and processes by healthcare providers that want to serve patients in this way.

Segmentation Overview:

Among different product types, Minimally Invasive Surgery segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Sacroiliac Joint Fusion market covered in Chapter 3:

Xtant Medical
CoreLink
Globus Medical
SI-BONE
Zyga Technology
Medtronic
Zimmer Biomet
SIGNUS Medizintechnik
VGI Medical
Life Spine
Orthofix

In Chapter 4 and Chapter 14.2, on the basis of types, the Sacroiliac Joint Fusion market from 2018 to 2029 is primarily split into:

Minimally Invasive Surgery
Open Surgery of Sacroiliac Joint Fusion

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Sacroiliac Joint Fusion market from 2018 to 2029 covers:

Hospitals
ASC

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)